{
    "organizations": [],
    "uuid": "7a53f400a1d1c2184df9fb25fbfd174ddf457af1",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/03/02/pr-newswire-juniper-pharmaceuticals-to-report-fourth-quarter-and-year-end-2017-results-on-march-8-2018.html",
    "ord_in_thread": 0,
    "title": "Juniper Pharmaceuticals to Report Fourth Quarter and Year-End on March 8, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOSTON, March 2, 2018 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP) (\"Juniper\" or the \"Company\"), will hold a conference call on March 8, 2018, to discuss the financial results for the fourth quarter and twelve months ended December 31, 2017, as follows:\nDate:\nMarch 8, 2018\nTime:\n8:30 a.m. EST\nDial-in numbers:\nToll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or\nInternational: (1-412-902-4218)\nAudio webcast (live & archive): www.juniperpharma.com , under 'Investors' or click here .\nThe teleconference replay will be available approximately one hour after completion through Thursday, March 15, 2018, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10117499.\nThe archived webcast will be available for one year via the aforementioned URLs.\nAbout Juniper Pharmaceuticals\nJuniper Pharmaceuticals, Inc.'s core businesses include its CRINONE ® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients. The Company is also leveraging its differentiated intravaginal ring technology, which offers the potential to address unmet needs in women's health. Please visit www.juniperpharma.com for more information.\nJuniper Pharmaceuticals™ is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU.\nCRINONE ® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan plc in the U.S.\nInvestor Contact:\nLaura Perry or Heather Savelle\nArgot Partners\n212-600-1902\nlaura@argotpartners.com\nheather@argotpartners.com\nTo receive Juniper's press releases, SEC filings or calendar alerts by email click here .\nFollow us on LinkedIn\nView original content with multimedia: http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-report-fourth-quarter-and-year-end-2017-results-on-march-8-2018-300607222.html\nSOURCE Juniper Pharmaceuticals, Inc.",
    "published": "2018-03-02T15:00:00.000+02:00",
    "crawled": "2018-03-02T15:16:31.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boston",
        "march",
        "juniper",
        "pharmaceutical",
        "nasdaq",
        "jnp",
        "juniper",
        "company",
        "hold",
        "conference",
        "call",
        "march",
        "discus",
        "financial",
        "result",
        "fourth",
        "quarter",
        "twelve",
        "month",
        "ended",
        "december",
        "follows",
        "date",
        "march",
        "time",
        "est",
        "number",
        "toll",
        "free",
        "canada",
        "international",
        "audio",
        "webcast",
        "live",
        "archive",
        "click",
        "teleconference",
        "replay",
        "available",
        "approximately",
        "one",
        "hour",
        "completion",
        "thursday",
        "march",
        "canada",
        "international",
        "replay",
        "access",
        "code",
        "archived",
        "webcast",
        "available",
        "one",
        "year",
        "via",
        "aforementioned",
        "url",
        "juniper",
        "pharmaceutical",
        "juniper",
        "pharmaceutical",
        "core",
        "business",
        "include",
        "crinone",
        "progesterone",
        "gel",
        "franchise",
        "juniper",
        "pharma",
        "service",
        "provides",
        "pharmaceutical",
        "development",
        "clinical",
        "trial",
        "manufacturing",
        "client",
        "company",
        "also",
        "leveraging",
        "differentiated",
        "intravaginal",
        "ring",
        "technology",
        "offer",
        "potential",
        "address",
        "unmet",
        "need",
        "woman",
        "health",
        "please",
        "visit",
        "information",
        "juniper",
        "trademark",
        "juniper",
        "pharmaceutical",
        "eu",
        "crinone",
        "registered",
        "trademark",
        "merck",
        "kgaa",
        "darmstadt",
        "germany",
        "outside",
        "allergan",
        "plc",
        "investor",
        "contact",
        "laura",
        "perry",
        "heather",
        "savelle",
        "argot",
        "partner",
        "laura",
        "heather",
        "receive",
        "juniper",
        "press",
        "release",
        "sec",
        "filing",
        "calendar",
        "alert",
        "email",
        "click",
        "follow",
        "u",
        "linkedin",
        "view",
        "original",
        "content",
        "multimedia",
        "http",
        "source",
        "juniper",
        "pharmaceutical",
        "inc"
    ]
}